Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the ...
You will get access to the full Best Colleges rankings, comprehensive information on each school, and premium tools and features. Subscribing to College Compass unlocks: Try our My Fit Custom Ranking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results